Abstract
Introduction
The prevalence of diabetes in young people is rising in India. The risk factors are high body mass index, lack of physical activity, and a positive family history. Young patients with type 2 diabetes mellitus are at a higher risk of longer disease duration and enhanced risk for chronic complications. We have studied the difference between early- and late-onset type 2 diabetes mellitus with respect to various glycemic and non-glycemic parameters.
Material and methods
This is an observational cross-sectional study conducted from November 2018 to October 2019. A total of 5142 patients were included in the study. The demographic, anthropometric, clinical, and biochemical information was obtained from the record of the patients.
Results
The number of patients diagnosed before 40 years of age was 1574 and 3568 patients after 40 years of age. There was female preponderance, 75.7% of the study subjects were from the urban area, and 60% had an income of < 2 lakh rupees per annum. Two-third (77%) of the patients were either overweight or obese. Significantly higher proportion of patients achieved glycemic and blood pressure targets in the early-onset type 2 diabetes mellitus group. The younger group had higher weight and body mass index, strong family history of diabetes, and more severe dyslipidemia. The comorbid conditions were significantly higher in the older age group.
Conclusion
Our study has revealed that about one-third of type 2 diabetes mellitus patients are diagnosed before 40 years of age. The younger patients are more obese. Two-third (73%) of these patients have uncontrolled diabetes.
Similar content being viewed by others
References
India State-Level Disease Burden Initiative Diabetes Collaborators. The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018;6(12):e1352–62.
Kim KS, Oh HJ, Kim JW, Lee YK, Kim SK, Park SW, et al. The clinical characteristics of the newly diagnosed early onset (< 40 years old) diabetes in outpatients’ clinic. Korean Diabetes J. 2010;34:119–25.
Breton MC, Guénette L, Amiche MA, Kayibanda JF, Grégoire JP, Moisan J. Burden of diabetes on the ability to work: a systematic review. Diabetes Care. 2013;36(3):740–9.
International Diabetes Federation. Diabetes Atlas. 3rd ed. Brussels: International Diabetes Federation; 2006. http://www.diabetesatlas.org/resources/previous-editions.html. Accessed 1 July 2020
International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels: International Diabetes Federation; 2013. http://www.diabetesatlas.org/resources/previous-editions.html. Accessed 1 April 2020
Holden SH, Barnett AH, Peters JR, Jenkins-Jones S, Poole CD, Morgan CL, et al. The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes Obes Metab. 2013;15:844–52.
Bolen S, Feldman L, Vassy J, Wilson L, Yeh HC, Marinopoulos S, et al. Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann Intern Med. 2007;147:386–99.
Ashraf H, Ahmad J. Cardiovascular outcome trials in type 2 diabetes: a critical analysis. Diabetes Metab Syndr. 2019;13:300–5.
Wexler DJ, Porneala B, Chang Y, Huang ES, Huffman JC, Grant RW. Diabetes differentially affects depression and self-rated health by age in the U.S. Diabetes Care. 2012;35:1575–7.
Sattar N, Rawshani A, Franzén S, Svensson AM, Rosengren A, Rosengren A, et al. Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks. Circulation. 2019;139:2228–37.
Ke C, Lau E, Shah BR, Stukel TA, Ma RC, So WY, et al. Excess burden of mental illness and hospitalization in young-onset type 2 diabetes: a population-based cohort study. Ann Intern Med. 2019;170:145–54.
Association AD. 1. Improving care and promoting health in populations: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S7–S13.
Lascar N, Brown J, Pattison H, Barnett AH, Bailey CJ, Bellary S. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 2018;6:69–80.
Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Concensus Group. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009 Feb;57:163–70.
Ashraf H, Laway BA, Afroze D, Wani AI. Evaluation of proinflammatory cytokines in obese vs non-obese patients with metabolic syndrome. Indian J Endocrinol Metab. 2018;22:751–6.
Sahoo SK, Zaidi G, Vipin VP, Chapla A, Thomas N, Yu L, et al. Heterogeneity in the aetiology of diabetes mellitus in young adults: a prospective study from north India. Indian J Med Res. 2019;149:479–88.
Mohan V, Pradeepa R. Epidemiology of diabetes in different regions of India. Health Adm. 2009;22:1–18.
Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord. 2001;25:1722–9.
Beigh SH, Jain S. Prevalence of metabolic syndrome and gender differences. Bioinformation. 2012;8:613–6.
Shobhana R, Rao PR, Lavanya A, Vijay V, Ramachandran A. Cost burden to diabetic patients with foot complications–a study from southern India. J Assoc Physicians India. 2000;48:1147–50.
Raheja BS, Kapur A, Bhoraskar A, Sathe SR, Jorgensen LN, Moorthi SR, et al. DiabCare Asia--India Study: diabetes care in India--current status. J Assoc Physicians India. 2001;49:717–22.
Ahmad J, Zubair M, Malik N, Zephy D, Raghav A. Glycemic and non-glycemic targets in younger and older North Indian subjects with type 2 diabetes in a tertiary care hospital: a 10 year’s retrospective data analysis. Diabetes Metab Syndr. 2016;10:S130–4.
Ramachandran A, Snehalatha C, Satyavani K, Latha E, Sasikala R, Vijay V. Prevalence of vascular complications and their risk factors in type 2 diabetes. J Assoc Physicians India. 1999;47:1152–6.
Dutta A, Naorem S, Singh P, Wangjam K. Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetics. Int J Diabetes Dev Ctries. 2005;25:30–3.
Dart AB, Sellers EA, Martens PJ, Rigatto C, Brownell MD, Dean HJ. High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care. 2012;35:1265–71.
Song SH, Gray TA. Early-onset type 2 diabetes: high risk for premature diabetic retinopathy. Diabetes Res Clin Pract. 2011;94:207–11.
Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, et al. SEARCH for diabetes in youth study. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med. 2017;376:1419–29.
Nizam S, Khalequzzaman M, Yatsuya H, Khanam PA, Sayeed MA, Naito H, et al. Incidence of young onset insulin-requiring diabetes mellitus among 18- to 30-year-olds in Dhaka, Bangladesh (1994-2003). Nagoya J Med Sci. 2012;74:149–56.
Tulloch-Reid MK, Boyne MS, Smikle MF, Choo-Kang EG, Parkes RH, Wright-Pascoe RA, et al. Clinical and laboratory features of youth onset type 2 diabetes in Jamaica. West Indian Med J. 2010;59:131–8.
Joham AE, Ranasinha S, Zoungas S, Moran L, Teede HJ. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2014;99:e447–52.
Steyn NP, Mann J, Bennett PH, Temple N, Zimmet P, Tuomilehto J, et al. Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr. 2004;7(1A):147–65.
Molyneaux L, Constantino M, Yue D. Strong family history predicts a younger age of onset for subjects diagnosed with type 2 diabetes. Diabetes Obes Metab. 2004;6:187–94.
Jali MV, Kambar S, Jali SM, Gowda S. Familial early onset of type-2 diabetes mellitus and its complications. N Am J Med Sci. 2009;1:377–80.
Katulanda GW, Katulanda P, Adler AI, Peiris SR, Draisey I, Wijeratne S, et al. Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns. Ann Clin Biochem. 2010;47(Pt 1):29–34.
Yeung RO, Zhang Y, Luk A, Yang W, Sobrepena L, Yoon KH, et al. Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort. Lancet Diabetes Endocrinol. 2014;2:935–43.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the three authors declare that they do not have any conflict of interest.
Research involving human participants and/or animals
Yes.
Informed consent
Approval was obtained from the institutional ethics committee. The procedures used in this study adhered to the tenets of the Declaration of Helsinki. Informed consent was obtained from all the individuals who participated in the study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ashraf, H., Faraz, A. & Ahmad, J. Comparison of clinical features, complication profile, and achievement of guideline targets in early- and late-onset type 2 diabetes patients from North India. Int J Diabetes Dev Ctries 41, 396–403 (2021). https://doi.org/10.1007/s13410-020-00905-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-020-00905-5